Editorial intelligencePeptide Unfiltered
Short topic previews to help you read research claims critically. Full investigations are not yet published.
01
Evidence reading frameworkEvidence is not a vibe.
Our framework separates the question people want answered from the question a study actually tested—then keeps approval, safety and product quality in their own lanes.
Read the evidence field guide 01
Evidence vs. hype · Topic previewBPC-157: the gap between recovery lore and human evidence
Animal models, anecdotes and a compelling mechanism can create a strong story. They still do not establish human efficacy, a validated protocol or product quality.
Read the related field guide →02
Product quality · Topic previewThe bad-vial problem is bigger than purity
A single HPLC percentage cannot establish identity, net content, sterility, endotoxin control, custody or formulation stability.
Read the related field guide →03
Regulatory action · Topic previewWhat an FDA compounding review does—and does not—mean
Regulatory categories, bulk-substance reviews and product approval are different questions. Blurring them creates false reassurance.
Read the related field guide →04
Clinical postmortem · Topic previewPromising mechanism, failed program
Why target engagement, a phase 2 signal and an impressive chart can still collapse under larger trials, safety or an endpoint mismatch.
Read the related field guide →05
Marketing claims · Topic previewWhen a blend borrows credibility
A named stack is a new intervention. It cannot inherit the strongest study, safest component or approval status inside the vial.
Read the related field guide →06
Community claims · Topic previewAnecdote is a signal—not a denominator
Community reports can surface questions. Without verification, controls and a denominator, they cannot quantify benefit or risk.
Read the related field guide →